A Study Evaluating Efficacy And Safety Of Perampanel Administered As Add-On Antiepileptic Drug Therapy In Patients With Unverricht-Lundborg Disease.
Latest Information Update: 10 Feb 2017
Price :
$35 *
At a glance
- Drugs Perampanel (Primary)
- Indications Unverricht-Lundborg syndrome
- Focus Adverse reactions; Therapeutic Use
- 10 Feb 2017 New trial record
- 06 Feb 2017 Results published in the Epilepsia journal.